Katia Bruxvoort, PhD, MPH

Dr
Kaiser Permanente Southern California

Disclosure: GlaxoSmithKlein (Individual(s) Involved: Self): Research Grant or Support

Presentation(s):

• 80 - COVID-19 Testing, Characteristics, and Outcomes Among People Living with HIV in an Integrated Health System

  Oral Abstract